Objective: To evaluate the effect of combined iron-zinc supplementation on micronutrient status, growth and morbidity. Design: Randomized, double-masked, placebo-controlled supplementation trial. Setting: Rural district of Que Vo, in the Red River Delta in Vietnam. Subjects: A total of 915 breast-fed infants aged 4-7 months were included and 784 completed the study. Interventions: The Fe-group received daily and for a 6-month period 10 mg of iron, the Zn-group 10 mg zinc, the Fe-Zn group 10 mg iron þ 10 mg zinc and the placebo group a placebo. Hemoglobin (Hb), serum ferritin (SF) and zinc (SZn), and anthropometry were measured before and at the end of the intervention. Morbidity was recorded daily. Results: Changes of Hb and SF were higher in both Fe and Fe þ Zn groups (respectively 22.6 and 20.6 g/l for Hb; 36.0 and 24.8 mg/l for SF) compared to Zn and placebo groups (Hb: 6.4 and 9.8 g/l; SF: À18.2 and À16.9 mg/l, Po0.0001). SZn increased more in Zn group (10.3 mmol/l) than in Fe þ Zn group (8.0 mmol/l, P ¼ 0.03) and more in these groups compared to Fe and placebo groups (1.6 and 1.2 mmol/l, Po0.0001). Weight gain was higher in the Zn group. No significant effects of supplementations on growth in length or morbidity. Conclusions: Combined iron-zinc supplementation had a positive effect on iron and zinc status in infants. However, the positive effect of zinc alone on SZn and weight would indicate a negative interaction of iron when added to zinc supplements. Sponsorship: UNICEF New York.